Kiniksa Pharmaceuticals International (KNSA) Net Margin (QoQ) (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Net Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.47 Bn | 43.51 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.72 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.45 Bn | 30.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.99 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 19.01 Bn | 18.13 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.14 Bn | 5.62 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.00 |
| Mar 31, 2026 | 352.00 |
| Dec 31, 2025 | -317.00 |
| Sep 30, 2025 | -118.00 |
| Jun 30, 2025 | 518.00 |
| Mar 31, 2025 | 1,345.00 |
| Dec 31, 2024 | 406.00 |
| Sep 30, 2024 | -771.00 |
| Jun 30, 2024 | 1,857.00 |
| Mar 31, 2024 | 3,688.00 |
| Dec 31, 2023 | -3,838.00 |
| Sep 30, 2023 | -4,161.00 |
| Jun 30, 2023 | 4,633.00 |
| Mar 31, 2023 | 3,432.00 |
| Dec 31, 2022 | -28,575.00 |
| Sep 30, 2022 | 30,013.00 |
| Jun 30, 2022 | 424.00 |
| Mar 31, 2022 | 15,683.00 |
| Dec 31, 2021 | 1,739.00 |
| Sep 30, 2021 | 28,696.00 |